Corteva Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/6/2026)
| Balance Sheet | Total Assets | 42,845,000,000.00 | ROE | 56.35 % |
| Balance Sheet | Total Equity | 24,144,000,000.00 | ROA | 2.55 % |
| Cashflow | Capital Expenditures | -591,000,000.00 | P/FCF | 21.36 |
| Cashflow | Free Cash Flow | 2,815,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 3,406,000,000.00 | P/CF | 17.65 |
| Income | Earnings per Share (diluted) | 0.24 | Div. Yield | 0.82 % |
| Income | Net Income | 1,094,000,000.00 | P/E | 55.83 |
| Income | Shares Outstanding | 4,486,684,715.00 | P/B | 2.49 |
| Income | Total Revenue | 17,401,000,000.00 | P/S | 3.46 |
Ratios calculated on: 10/14/2026
Company Description
Corteva, Inc. provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health. The company is based in Wilmington, Delaware. Corteva, Inc. operates independently of DowDuPont Inc. as of June 1, 2019.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.corteva.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more